Multiple Myeloma Research Consortium (MMRC) Announces Data Presentations at 46th Annual American Society of Clinical Oncology (ASCO) Annual Meeting

• Norwalk, Conn., Jun. 1, 2010

Multiple Myeloma Research Consortium (MMRC) Initiates Phase IB/II Clinical Trial of Treanda^® in Combination with Revlimid^® and Dexamethasone in Patients with Relapsed Multiple Myeloma

• Norwalk, Conn., Apr. 06, 2010

Multiple Myeloma Research Consortium (MMRC) Unveils 16 Abstracts at ASH

• Norwalk, Conn., Nov. 23, 2009

MMRC Multiple Myeloma Genomics Initiative First to Sequence Complete Myeloma Genomes

• Norwalk, Conn., Jul. 27, 2009

Multiple Myeloma Research Consortium (MMRC) Activates Clinical Trials 30-40 Percent Faster Than Industry Standard

• Norwalk, Conn., Jun. 18, 2009

MMRF and the Broad Institute of MIT and Harvard Announce Collaboration to Perform Whole Genome Sequencing of Multiple Myeloma Samples

• Norwalk, Conn. and Cambridge, Mass., May 18, 2009

AACR Awards Centennial Medals for Distinguished Public Service

• Denver, Colo., Apr. 14, 2009

Multiple Myeloma Research Consortium (MMRC) and Merck initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients

• Norwalk, Conn., Jan. 16, 2009

Data from eight clinical trials facilitated by the Multiple Myeloma Research Consortium (MMRC) presented at the American Society of Hematology (ASH) annual meeting

• Norwalk, Conn., Dec. 10, 2008

Multiple Myeloma Research Consortium (MMRC) Honors Dr. Andrzej Jakubowiak, University of Michigan with 2008 Center of the Year Award

• Norwalk, Conn., Dec. 08, 2008

The Multiple Myeloma Research Consortium (MMRC) Partners with Celgene Corporation on Phase I/II Trial of Pomalidomide (CC-4047) in Relapsed and Refractory Multiple Myeloma Patients

• Norwalk, Conn., Aug. 22, 2008

The Multiple Myeloma Research Consortium (MMRC) Announces Initiation of First Four-Drug Combination Study to Treat Newly Diagnosed Multiple Myeloma Patients

• Norwalk, Conn., Aug. 13, 2008

The Multiple Myeloma Research Consortium (MMRC) Announces the Initiation of Phase I/II Study of Elotuzumab (Huluc63) Monoclonal Antibody in Combination with Velcade

• Norwalk, Conn., Jul. 18, 2008

The Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) Name Susan L. Kelley, M.D., Chief Medical Officer

• Norwalk, Conn., Jul. 07, 2008

Multiple Myeloma Research Consortium (MMRC) Expands Model to Fifteen Member Institutions

• Norwalk, Conn., Jun. 27, 2008

Multiple Myeloma Research Foundation Chicago Awards Dinner Raises More Than $750,000 for Myeloma Research

• Chicago, Il., May 01, 2008

Multiple Myeloma Research Consortium and Sunesis Pharmaceuticals Present Data on SNS-032 at American Association of Cancer Research Annual Meeting

• San Diego, Calif., Apr. 16, 2008

Semafore and Multiple Myeloma Research Consortium (MMRC) dose first patient in phase i study of targeted pi3 kinase (PI3K) inhibitor

• Indianapolis and Norwalk, Conn., Jan. 07, 2008

Sunesis Pharmaceuticals and the Multiple Myeloma Research Consortium Form Collaboration to Study SNS-032 in Multiple Myeloma

• South San Francisco, Calif., Dec. 19, 2007

MMRC Genomics Initiative Selected for Two Presentations at American Society of Hematology (ASH) Annual Meeting

• Atlanta, Dec. 10, 2007

Multiple Myeloma Research Consortium (MMRC) Honors Emory University, Dr. Sagar Lonial with 2007 Center of the Year Award

• Norwalk, Conn., Dec. 07, 2007

Multiple Myeloma Research Foundation 11th Annual Friends For Life Fall Gala Raises More Than $2 Million to Accelerate a Cure for Blood Cancer

• Norwalk, Conn., Oct. 30, 2007

The Multiple Myeloma Research Consortium Commences Phase I/II Combination Study for the Treatment of Multiple Myeloma

• Norwalk, Conn., Sep. 17, 2007

The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma

• Norwalk, Conn., Aug. 15, 2007

Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor

• Norwalk, Conn., Aug. 14, 2007

MMRF, MMRC Launch Multiple Myeloma Genomics Portal

• Norwalk, Conn., Aug. 1, 2007

Multiple Myeloma Research Consortium (MMRC), Emory University Commence Multi-Center Combination Study for the Treatment of Multiple Myeloma

• Norwalk, Conn., June 14, 2007

The Multiple Myeloma Research Consortium and Nereus Pharmaceuticals Initiate Clinical Trial Investigating NPI-0052 to Treat Multiple Myeloma

• San Diego and Norwalk, Conn., Apr. 16, 2007

The Multiple Myeloma Research Consortium (MMRC) and Keryx Biopharmaceuticals Commence Multi-Center Combination Study for the Treatment of Multiple Myeloma

• New York and Norwalk, Conn., Dec. 28, 2006

Multiple Myeloma Research Consortium Founder, CEO Receives American Society of Clinical Oncology’s Partners in Progress Award

• Norwalk, Conn., Jun. 4, 2006

Four New Cancer Centers Join Multiple Myeloma Research Consortium

• New Canaan, Conn., Apr. 10, 2006

Multiple Myeloma Research Consortium (MMRC) Names LabVantage as Preferred Biobanking Partner

• New Canaan, Conn., Apr., 2006

Multiple Myeloma Research Consortium (MMRC) Names MDS Pharma Services as Preferred Contract Research Organization (CRO)

• New Canaan, Conn., Apr., 2006

Multiple Myeloma Research Consortium (MMRC) Launches Myeloma Genome Mapping Program

• New Canaan, Conn., Mar. 27, 2006

Three New Cancer Centers Join Multiple Myeloma Research Consortium

• New Canaan, Conn., Sep. 8, 2005

Chiron and the Multiple Myeloma Research Consortium Announce Initiation of Phase I Clinical Trial for CHIR-258

• Emeryville, Calif. & New Canaan, Conn., Jun. 2, 2005

Multiple Myeloma Research Consortium Opens GLP-Quality Tissue Bank

• New Canaan, Conn., Apr. 18, 2005

Edward J. Phillips, Son of "Dear Abby" and Creator of Belvedere Vodka, Donates $1 Million to Multiple Myeloma Research Consortium

• New Canaan, Conn., Jan. 27, 2005

Multiple Myeloma Research Consortium Awarded $1.5 Million Grant to Support Tissue and Data Banks

• New Canaan, Conn., Sept. 14, 2004

Multiple Myeloma Research Consortium Launched as New Model to Accelerate Drug Development for Blood Cancer

• New Canaan, Conn., Aug. 17, 2004